KK Therapeutics ApS

KK Therapeutics ApS (CVR number: 40378111) is a company from KØBENHAVN. The company recorded a gross profit of -30 kDKK in 2019. The operating profit was -30 kDKK, while net earnings were -32.8 kDKK. The profitability of the company measured by Return on Assets (ROA) was -127.9 %, which can be considered poor and Return on Equity (ROE) was -190.5 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 73.4 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. KK Therapeutics ApS's liquidity measured by quick ratio was 3.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.